Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00219063
Status:
COMPLETED
Last Update Posted:
2017-05-17
First Post:
2005-09-12
Brief Title:
A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 26 Week Double-blind Randomized Multicenter Parallel Group Active-controlled Study Comparing Aliskiren to Ramipril With Optional Addition of Hydrochlorothiazide Followed by a 4 Week Double-blind Randomized Placebo-controlled Withdrawal in Patients With Essential Hypertension
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the aliskiren regimen versus the ramipril regimen on reduction in Blood Pressure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None